Licensing and Technology Transfer
Expert-defined terms from the Professional Certificate in Intellectual Property Law course at London School of Business and Administration. Free to read, free to share, paired with a professional course.
Assignment – A legal transfer of ownership of an intellectual property ri… #
Assignment – A legal transfer of ownership of an intellectual property right from one party (assignor) to another (assignee).
Explanation #
The assignor relinquishes all present and future rights, and the assignee steps into the shoes of the original owner.
Example #
A university researcher assigns a patented invention to a start‑up for commercial exploitation.
Practical application #
Enables clean ownership structures for investors.
Challenges #
Ensuring that the assignment is recorded with the appropriate IP office and that any existing licenses are honored.
Advance Payment – A sum of money paid by the licensee to the licensor bef… #
Advance Payment – A sum of money paid by the licensee to the licensor before any commercial activity begins, often used to secure access to the technology.
Explanation #
Serves as a risk‑mitigation tool for the licensor and may be credited against future royalties.
Example #
A biotech firm pays an advance to a university to obtain an exclusive license to a gene‑editing platform.
Practical application #
Provides immediate cash flow for further development.
Challenges #
Determining a fair amount and negotiating repayment provisions if the product never reaches market.
Antitrust Considerations – Legal analysis of whether a licensing arrangem… #
Antitrust Considerations – Legal analysis of whether a licensing arrangement unduly restrains competition.
Explanation #
Licenses that grant exclusive rights in a market may be scrutinized for monopolistic effects.
Example #
A dominant software company granting exclusive licenses to a few hardware manufacturers could raise antitrust concerns.
Practical application #
Requires structuring agreements to include non‑exclusive options or carve‑outs.
Challenges #
Balancing the need for exclusive rights to incentivize investment with compliance to competition regulations.
Bayh‑Dole Act – U #
S. legislation (1980) that allows universities, small businesses, and non‑profits to retain title to inventions arising from federally funded research.
Explanation #
Encourages commercialization by giving institutions the right to license their inventions.
Example #
A university patents a medical device invented under a NIH grant and licenses it to a commercial partner.
Practical application #
Provides a mechanism for technology transfer offices to generate revenue.
Challenges #
Managing government rights, such as preference for licensing to U.S. industry, and ensuring compliance with reporting obligations.
Breakthrough Innovation – A novel technology that significantly advances… #
Breakthrough Innovation – A novel technology that significantly advances the state of the art and creates new markets.
Explanation #
Often forms the core of high‑value licensing deals due to its commercial potential.
Example #
CRISPR‑Cas9 gene‑editing technology is considered a breakthrough innovation.
Practical application #
Attracts venture capital and strategic partners.
Challenges #
Uncertainty about regulatory pathways and market adoption can affect licensing terms.
Cross‑Licensing – An agreement where two parties grant each other rights… #
Cross‑Licensing – An agreement where two parties grant each other rights to their respective patents.
Explanation #
Reduces litigation risk and facilitates product development by allowing use of each other’s technology.
Example #
Two semiconductor firms cross‑license patents covering complementary chip designs.
Practical application #
Enables faster time‑to‑market for complex products.
Challenges #
Valuing each side’s portfolio and preventing anti‑competitive collusion.
Copyright – Legal protection for original works of authorship, such as so… #
Copyright – Legal protection for original works of authorship, such as software, literature, and artistic creations.
Explanation #
Grants exclusive rights to reproduce, distribute, and publicly display the work.
Example #
A software company licenses its source code to a partner under a source‑code license.
Practical application #
Forms the basis of many software licensing agreements.
Challenges #
Determining infringement in the digital environment and managing international protection.
Due Diligence – The investigative process performed by a potential licens… #
Due Diligence – The investigative process performed by a potential licensee to assess the validity, scope, and enforceability of IP assets.
Explanation #
Involves reviewing patent status, freedom‑to‑operate, and existing encumbrances.
Example #
A pharmaceutical firm conducts due diligence on a university‑owned drug candidate before signing a license.
Practical application #
Helps avoid costly post‑signing disputes.
Challenges #
Access to confidential information and interpreting complex patent claims.
Exclusivity – The grant of sole rights to a licensee to exploit an IP ass… #
Exclusivity – The grant of sole rights to a licensee to exploit an IP asset within a defined field, territory, or time period.
Explanation #
Provides a competitive advantage but may raise antitrust concerns if the market is limited.
Example #
An exclusive license to develop a vaccine in the United States.
Practical application #
Encourages substantial investment by the licensee.
Challenges #
Determining appropriate scope and ensuring compliance with competition law.
Franchise – A business model where a franchisor grants a licensee the rig… #
Franchise – A business model where a franchisor grants a licensee the right to use its brand, operating system, and support services.
Explanation #
Combines IP licensing with ongoing business support and quality control.
Example #
A fast‑food chain grants franchise rights to operate restaurants under its name.
Practical application #
Enables rapid market expansion with lower capital outlay for the franchisor.
Challenges #
Monitoring compliance and protecting brand reputation.
Grant – The act of conferring a license or other IP right, often by a gov… #
Grant – The act of conferring a license or other IP right, often by a government or funding agency.
Explanation #
May involve conditions such as reporting, royalty payments, or use restrictions.
Example #
A government agency grants a research institute a license to commercialize a patented technology.
Practical application #
Facilitates public‑to‑private technology transfer.
Challenges #
Ensuring that grant terms are clear and enforceable.
Holdback – A contractual provision that retains a portion of payments (of… #
Holdback – A contractual provision that retains a portion of payments (often royalties) until certain milestones are met.
Explanation #
Protects the licensor against under‑performance by the licensee.
Example #
A royalty holdback of 20 % until the product achieves FDA approval.
Practical application #
Aligns incentives for product development.
Challenges #
Defining objective milestones and managing cash flow for the licensee.
IP Audit – A systematic review of an organization’s intellectual property… #
IP Audit – A systematic review of an organization’s intellectual property assets to identify, assess, and value them.
Explanation #
Provides the foundation for licensing strategies and risk management.
Example #
A start‑up conducts an IP audit before seeking investors.
Practical application #
Highlights gaps, such as missing patents, and informs licensing negotiations.
Challenges #
Requires specialized expertise and may uncover hidden liabilities.
Joint Development Agreement (JDA) – A contract whereby two or more partie… #
Joint Development Agreement (JDA) – A contract whereby two or more parties collaborate to create new technology and share resulting IP.
Explanation #
Defines contribution, ownership, and licensing rights for jointly created inventions.
Example #
A pharma company and a biotech firm enter a JDA to develop a new antibody platform.
Practical application #
Pools resources and expertise.
Challenges #
Determining joint ownership percentages and handling future licensing disputes.
Know‑How – Confidential technical information, processes, or expertise th… #
Know‑How – Confidential technical information, processes, or expertise that provides a competitive edge but is not protected by patents.
Explanation #
Often transferred under a license or material transfer agreement with confidentiality clauses.
Example #
A manufacturing firm licenses proprietary process know‑how for producing a specialty polymer.
Practical application #
Enables rapid scale‑up without public disclosure.
Challenges #
Protecting the information from unauthorized disclosure and reverse engineering.
License – A contractual grant of permission to use, practice, or commerci… #
License – A contractual grant of permission to use, practice, or commercialize an IP right under defined conditions.
Explanation #
Can be exclusive, non‑exclusive, field‑of‑use, or territory‑specific.
Example #
A software license allowing a client to run a program on a limited number of devices.
Practical application #
Generates revenue streams for IP owners.
Challenges #
Drafting clear scope, royalty structures, and termination clauses.
Licensee – The party receiving rights under a license agreement, typicall… #
Licensee – The party receiving rights under a license agreement, typically responsible for paying royalties and complying with usage restrictions.
Explanation #
May be a commercial entity, academic institution, or individual.
Example #
A medical device company that licenses a patented sensor technology.
Practical application #
Gains access to technology without bearing development costs.
Challenges #
Meeting performance milestones and maintaining confidentiality.
Licensor – The owner of an IP right who grants a license to a third party… #
Licensor – The owner of an IP right who grants a license to a third party, often retaining certain rights and receiving compensation.
Explanation #
Controls the scope of use and can impose quality standards.
Example #
A university technology transfer office acting as licensor for a patented nanomaterial.
Practical application #
Monetizes research outcomes.
Challenges #
Monitoring compliance and protecting the underlying IP.
Material Transfer Agreement (MTA) – A contract governing the exchange of… #
Material Transfer Agreement (MTA) – A contract governing the exchange of tangible research materials between parties, often including IP clauses.
Explanation #
Defines permitted use, ownership of derivatives, and confidentiality.
Example #
A university sends a plasmid to a biotech start‑up under an MTA that requires the start‑up to grant the university a royalty‑free license on any inventions.
Practical application #
Facilitates collaborative research while protecting IP.
Challenges #
Negotiating terms that balance openness with commercial interests.
Non‑Disclosure Agreement (NDA) – A legal instrument that obligates partie… #
Non‑Disclosure Agreement (NDA) – A legal instrument that obligates parties to keep shared confidential information secret.
Explanation #
Often a prerequisite for discussing undisclosed inventions or licensing terms.
Example #
Before revealing a new algorithm, a company requires a potential partner to sign an NDA.
Practical application #
Enables safe exchange of proprietary data.
Challenges #
Defining what constitutes confidential information and enforcing remedies for breach.
Option Agreement – A contract that gives a party the right, but not the o… #
Option Agreement – A contract that gives a party the right, but not the obligation, to acquire a license or IP asset at a future date under predetermined terms.
Explanation #
Allows a licensee to evaluate commercial potential before committing fully.
Example #
A pharmaceutical firm obtains an option to license a university‑owned compound after pre‑clinical data are favorable.
Practical application #
Reduces upfront risk while securing future access.
Challenges #
Setting fair option fees and defining trigger events.
Patent – A statutory right granting the holder exclusive control over an… #
Patent – A statutory right granting the holder exclusive control over an invention for a limited period, typically 20 years from filing.
Explanation #
Prevents others from making, using, selling, or importing the claimed invention without permission.
Example #
A patented drug delivery system licensed to a manufacturer.
Practical application #
Forms the core asset in many technology transfer deals.
Challenges #
Maintaining the patent through payments, handling invalidity challenges, and managing global filing strategies.
Patent Pool – A consortium of patent owners who aggregate their patents a… #
Patent Pool – A consortium of patent owners who aggregate their patents and grant licenses to third parties under a single, often royalty‑based, agreement.
Explanation #
Simplifies access to multiple patents needed for a technology, such as video codecs.
Example #
The MPEG‑LA pool licensing essential patents for video compression standards.
Practical application #
Reduces transaction costs and speeds product development.
Challenges #
Antitrust scrutiny and equitable royalty distribution among members.
Patent Valuation – The process of estimating the monetary worth of a pate… #
Patent Valuation – The process of estimating the monetary worth of a patent or portfolio based on factors such as market size, remaining life, and enforceability.
Explanation #
Used for licensing negotiations, financing, and M&A transactions.
Example #
A start‑up presents a valuation of $15 million for a patented CRISPR platform when negotiating a license.
Practical application #
Provides a basis for royalty rates and upfront fees.
Challenges #
Predicting future revenue streams and accounting for regulatory risk.
Performance Milestones – Pre‑defined development, regulatory, or commerci… #
Performance Milestones – Pre‑defined development, regulatory, or commercial targets that a licensee must achieve under a licensing agreement.
Explanation #
Trigger subsequent royalty payments or release of additional rights.
Example #
A biotech license includes a milestone for completing Phase II clinical trials.
Practical application #
Aligns incentives and ensures progress.
Challenges #
Setting realistic, measurable milestones and handling delays.
Royalty – A recurring payment made by a licensee to a licensor, usually e… #
Royalty – A recurring payment made by a licensee to a licensor, usually expressed as a percentage of sales or a fixed per‑unit amount.
Explanation #
Compensates the licensor for the use of its IP over time.
Example #
A 5 % royalty on net sales of a medical device incorporating a patented component.
Practical application #
Provides ongoing revenue tied to commercial success.
Challenges #
Determining an appropriate base, auditing sales, and handling currency fluctuations.
Royalty Base – The denominator used to calculate royalty payments, such a… #
Royalty Base – The denominator used to calculate royalty payments, such as net sales, gross revenue, or units sold.
Explanation #
Impacts the amount of royalties paid and can be a point of negotiation.
Example #
Using “net sales after discounts” as the royalty base to reflect actual revenue.
Practical application #
Aligns royalty with the licensee’s profitability.
Challenges #
Defining exclusions (e.g., taxes, rebates) and ensuring transparent accounting.
Scope of License – The defined parameters of a license, including field‑o… #
Scope of License – The defined parameters of a license, including field‑of‑use, territory, duration, and exclusivity.
Explanation #
Determines where and how the IP may be exploited.
Example #
An exclusive license limited to “oncology therapeutics in North America for ten years.”
Practical application #
Allows the licensor to retain rights in other fields or regions.
Challenges #
Drafting precise language to avoid unintended encroachments.
Sub‑licensing – The act of a licensee granting part of its licensed right… #
Sub‑licensing – The act of a licensee granting part of its licensed rights to a third party, usually with the licensor’s consent.
Explanation #
Expands the reach of the technology while generating additional revenue for the original licensor.
Example #
A primary licensee sub‑licenses a software component to a system integrator.
Practical application #
Enables broader market penetration.
Challenges #
Ensuring sub‑licensees comply with original terms and managing royalties on multiple tiers.
Technology Transfer Office (TTO) – An institutional unit, often within a… #
Technology Transfer Office (TTO) – An institutional unit, often within a university or research institute, responsible for managing IP, licensing, and commercialization activities.
Explanation #
Acts as the licensor, negotiates agreements, and supports spin‑outs.
Example #
The MIT TTO negotiates a license for a nanofabrication process to a semiconductor company.
Practical application #
Bridges the gap between academic research and market.
Challenges #
Balancing academic openness with commercial confidentiality and aligning incentives for researchers.
University Spin‑out – A new company formed to commercialize technology de… #
University Spin‑out – A new company formed to commercialize technology developed within a university, often supported by the TTO and venture capital.
Explanation #
Typically receives exclusive licenses to the underlying IP.
Example #
A spin‑out founded by PhD students to market a patented drug delivery system.
Practical application #
Accelerates market entry and provides revenue to the university.
Challenges #
Securing sufficient funding, managing founder‑licensor relationships, and navigating IP ownership.
Valuation Methods – Techniques used to estimate the financial value of IP… #
Valuation Methods – Techniques used to estimate the financial value of IP, including income, market, and cost approaches.
Explanation #
Each method considers different aspects such as future cash flows, comparable sales, or development costs.
Example #
Applying a discounted cash flow model to value a patent expected to generate $10 million annually over ten years.
Practical application #
Informs royalty negotiations and licensing fees.
Challenges #
Selecting appropriate assumptions and dealing with uncertainty.
Work‑Made‑For‑Hire – A work created by an employee or contractor that, by… #
Work‑Made‑For‑Hire – A work created by an employee or contractor that, by law, belongs to the employer or commissioning party unless otherwise agreed.
Explanation #
Simplifies ownership of software, designs, or documentation produced during a project.
Example #
A software developer creates code for a client; the client automatically owns the code under work‑made‑for‑hire doctrine.
Practical application #
Avoids the need for separate assignment agreements.
Challenges #
Ensuring that the agreement explicitly states work‑made‑for‑hire status, especially with independent contractors.
eXclusive License – A licensing arrangement that grants the licensee excl… #
eXclusive License – A licensing arrangement that grants the licensee exclusive rights within a defined scope, while the licensor retains no other rights in that scope.
Explanation #
Provides the licensee with a competitive advantage but often requires higher royalty rates or upfront payments.
Example #
An exclusive license to develop a vaccine for a specific disease in the EU.
Practical application #
Incentivizes large investments in product development.
Challenges #
Assessing market risk and ensuring the licensor does not breach other commitments.
Yield Clause – A provision in a licensing agreement that ties royalty rat… #
Yield Clause – A provision in a licensing agreement that ties royalty rates to the profitability or sales performance of the licensed product.
Explanation #
Allows royalties to increase as the product becomes more successful.
Example #
A royalty rate that escalates from 3 % to 7 % once annual sales exceed $50 million.
Practical application #
Aligns interests of licensor and licensee across the product lifecycle.
Challenges #
Accurately measuring profitability and preventing manipulation of financial statements.
Zero‑Royalty License – A licensing arrangement that does not require roya… #
Zero‑Royalty License – A licensing arrangement that does not require royalty payments, often in exchange for an upfront fee, equity, or other consideration.
Explanation #
May be used when the licensor seeks immediate cash or strategic partnership.
Example #
A start‑up receives a zero‑royalty license to a patented sensor technology in return for a $2 million cash payment and board representation.
Practical application #
Simplifies accounting and provides predictable costs for the licensee.
Challenges #
Ensuring the upfront consideration adequately reflects the IP’s future value.
Acceleration Clause – A contract term that speeds up payment obligations… #
Acceleration Clause – A contract term that speeds up payment obligations (such as royalties or milestones) if certain events occur, like a change of control.
Explanation #
Protects the licensor from loss of revenue due to corporate restructuring.
Example #
A royalty acceleration clause that requires full payment upon the licensee’s acquisition.
Practical application #
Provides financial security for the licensor.
Challenges #
Negotiating fair triggers and avoiding overly burdensome obligations for the licensee.
Bench‑Scale Production – Small‑scale manufacturing used during early deve… #
Bench‑Scale Production – Small‑scale manufacturing used during early development to produce limited quantities of a product for testing.
Explanation #
Often covered by a license that permits limited commercial use.
Example #
A license allowing bench‑scale production of a new polymer for internal research.
Practical application #
Enables proof‑of‑concept without full commercial commitment.
Challenges #
Defining the permissible volume and ensuring the licensee does not exceed it.
Best‑Efforts Clause – A contractual provision obligating a party to use c… #
Best‑Efforts Clause – A contractual provision obligating a party to use commercially reasonable efforts to achieve specified objectives.
Explanation #
Provides flexibility while still imposing a performance expectation.
Example #
A licensing agreement includes a best‑efforts clause for filing a regulatory submission within five years.
Practical application #
Encourages progress without strict deadlines.
Challenges #
Interpreting “best efforts” and resolving disputes over adequacy of effort.
Brand Licensing – The licensing of a trademark or brand name to a third p… #
Brand Licensing – The licensing of a trademark or brand name to a third party for use on products or services.
Explanation #
Allows the brand owner to extend its reach while receiving royalties or fees.
Example #
A fashion label licenses its logo to a watch manufacturer.
Practical application #
Generates revenue and increases brand visibility.
Challenges #
Maintaining quality control and protecting brand reputation.
Change‑of‑Control Provision – A clause that addresses the rights and obli… #
Change‑of‑Control Provision – A clause that addresses the rights and obligations of parties if one party undergoes a merger, acquisition, or other ownership change.
Explanation #
May trigger termination, royalty acceleration, or renegotiation.
Example #
A license terminates automatically if the licensor is acquired by a competitor.
Practical application #
Provides certainty for both parties in M&A scenarios.
Challenges #
Drafting balanced language that protects interests without deterring investment.
Commercialization Milestone – A specific market‑oriented target, such as… #
Commercialization Milestone – A specific market‑oriented target, such as product launch, sales volume, or market share, that triggers payments or rights under a license.
Explanation #
Aligns the licensor’s compensation with commercial success.
Example #
A $1 million payment due when the licensed drug achieves $10 million in annual sales.
Practical application #
Encourages the licensee to prioritize market entry.
Challenges #
Measuring achievement accurately and handling market fluctuations.
Confidential Disclosure Agreement (CDA) – Another term for a non‑disclosu… #
Confidential Disclosure Agreement (CDA) – Another term for a non‑disclosure agreement, emphasizing the exchange of confidential information for evaluation purposes.
Explanation #
Allows parties to discuss potential licensing without risking loss of trade secrets.
Example #
A pharma company signs a CDA before reviewing a university’s pre‑clinical data.
Practical application #
Facilitates early‑stage negotiations.
Challenges #
Defining the scope of confidential information and the duration of the obligation.
Contingent Royalty – A royalty payment that is dependent on future events… #
Contingent Royalty – A royalty payment that is dependent on future events, such as regulatory approval or achievement of sales thresholds.
Explanation #
Aligns payment with risk and success.
Example #
A royalty that only becomes payable after the product receives FDA clearance.
Practical application #
Reduces upfront financial burden for the licensee.
Challenges #
Negotiating trigger events and ensuring transparent reporting.
Co‑Marketing Agreement – A collaborative arrangement where two parties jo… #
Co‑Marketing Agreement – A collaborative arrangement where two parties jointly promote each other’s products or technologies.
Explanation #
Often accompanies a licensing deal to maximize market impact.
Example #
A software vendor and hardware manufacturer co‑market a bundled solution.
Practical application #
Leverages complementary brand strengths.
Challenges #
Aligning marketing strategies and measuring contribution to sales.
Co‑Ownership – Joint ownership of IP rights by two or more parties, each… #
Co‑Ownership – Joint ownership of IP rights by two or more parties, each holding an undivided interest.
Explanation #
Requires agreement on licensing, enforcement, and disposition.
Example #
Two research institutions co‑own a patent resulting from a collaborative project.
Practical application #
Facilitates shared commercialization benefits.
Challenges #
Decision‑making deadlocks and coordinating royalty distribution.
Compulsory License – A government‑issued permission to use patented techn… #
Compulsory License – A government‑issued permission to use patented technology without the patent holder’s consent, usually for public interest reasons.
Explanation #
May be invoked during health emergencies or for essential medicines.
Example #
A national health authority grants a compulsory license for a patented HIV drug to increase access.
Practical application #
Balances IP rights with societal needs.
Challenges #
Potential compensation disputes and impact on future innovation incentives.
Confidentiality Obligation – The duty imposed by an NDA or contract to pr… #
Confidentiality Obligation – The duty imposed by an NDA or contract to protect disclosed information from unauthorized disclosure or use.
Explanation #
Typically survives the termination of the underlying agreement.
Example #
An MTA includes a confidentiality obligation to keep the transferred cell line data secret.
Practical application #
Safeguards competitive advantage.
Challenges #
Enforcing the obligation across jurisdictions and proving breach.
Continuing Royalty – A royalty that persists for the life of the licensed… #
Continuing Royalty – A royalty that persists for the life of the licensed product, as opposed to a one‑time payment.
Explanation #
Provides a steady income stream to the licensor.
Example #
A 2 % continuing royalty on net sales of a medical device.
Practical application #
Aligns long‑term interests of both parties.
Challenges #
Monitoring sales and ensuring accurate reporting over many years.
Copyright Assignment – The transfer of ownership of copyrighted works fro… #
Copyright Assignment – The transfer of ownership of copyrighted works from creator to another party, often required for commercial exploitation.
Explanation #
Enables the assignee to enforce and license the work.
Example #
A graphic designer assigns copyright of a logo to a client.
Practical application #
Clears title for commercial use.
Challenges #
Ensuring the assignment covers all derivative works and future adaptations.
Cross‑Border Licensing – Licensing agreements that involve parties in dif… #
Cross‑Border Licensing – Licensing agreements that involve parties in different countries, requiring consideration of multiple legal regimes.
Explanation #
Must address issues such as jurisdiction, enforcement, and currency.
Example #
A U.S. company licenses a European patent to an Asian manufacturer.
Practical application #
Expands market reach.
Challenges #
Coordinating with local counsel and managing divergent regulatory environments.
Data Exclusivity – A period during which clinical trial data submitted to… #
Data Exclusivity – A period during which clinical trial data submitted to a regulatory authority cannot be used by competitors to obtain marketing approval.
Explanation #
Complements patent protection for pharmaceuticals.
Example #
The European Medicines Agency grants eight years of data exclusivity for a new drug.
Practical application #
Provides a window of commercial advantage even after patent expiry.
Challenges #
Understanding overlapping periods with patents and navigating compulsory licensing.
Defensive Publication – The act of publishing an invention to prevent oth… #
Defensive Publication – The act of publishing an invention to prevent others from obtaining a patent on the same subject, thereby creating prior art.
Explanation #
Used when commercial exploitation is not intended but blocking competitors is desired.
Example #
A researcher publishes a detailed protocol to prevent competitors from patenting it.
Practical application #
Protects freedom to operate.
Challenges #
Ensuring the publication meets legal standards for prior art.
Derivative Work – A new creation that incorporates or is based upon pre‑e… #
Derivative Work – A new creation that incorporates or is based upon pre‑existing copyrighted material.
Explanation #
Requires permission from the original copyright holder unless covered by a license.
Example #
A software module that builds upon an open‑source library.
Practical application #
Enables innovation on existing platforms.
Challenges #
Determining ownership of the derivative and complying with licensing terms.
Digital Rights Management (DRM) – Technological measures used to control… #
Digital Rights Management (DRM) – Technological measures used to control the use of digital content and prevent unauthorized copying or distribution.
Explanation #
Often embedded in software licenses to enforce usage restrictions.
Example #
A music streaming service uses DRM to limit offline playback.
Practical application #
Protects revenue streams for digital media owners.
Challenges #
Balancing user experience with security and dealing with circumvention laws.
Divestiture Clause – A provision that requires a party to sell or transfe… #
Divestiture Clause – A provision that requires a party to sell or transfer its interest in IP if certain conditions arise, such as antitrust rulings.
Explanation #
Protects the other party from being forced to abandon the technology.
Example #
A licensing agreement includes a divestiture clause triggered by an EU competition authority decision.
Practical application #
Provides a contingency plan for regulatory risk.
Challenges #
Valuing the IP at the time of divestiture and ensuring smooth transfer.
Dual‑Use Technology – Technology that can be used for both civilian and m… #
Dual‑Use Technology – Technology that can be used for both civilian and military applications, often subject to export controls.
Explanation #
Licensing must consider compliance with laws such as the U.S. Export Administration Regulations.
Example #
A semiconductor process that could be employed in consumer electronics or missile guidance systems.
Practical application #
Opens high‑value markets while requiring careful compliance.
Challenges #
Obtaining export licenses and managing the risk of sanctions.
Equity‑Based License – A licensing arrangement where the licensor receive… #
Equity‑Based License – A licensing arrangement where the licensor receives equity in the licensee’s company instead of—or in addition to—cash payments.
Explanation #
Aligns the licensor’s interests with the licensee’s success.
Example #
A university grants an equity‑based license to a start‑up, receiving a 5 % ownership stake.
Practical application #
Provides upside potential for the licensor.
Challenges #
Valuing the equity, dealing with dilution, and handling exit events.
Exclusive Field‑of‑Use – A restriction that grants exclusivity only withi… #
Exclusive Field‑of‑Use – A restriction that grants exclusivity only within a defined technical field, allowing the licensor to license the same IP in other fields.
Explanation #
Enables the licensor to maximize revenue across multiple markets.
Example #
An exclusive license for “automotive applications” while retaining rights for “industrial robotics.”
Practical application #
Tailors exclusivity to the licensee’s expertise.
Challenges #
Precisely defining field boundaries to avoid disputes.
Force‑Majeure Clause – A contractual provision that suspends obligations… #
g., natural disasters, war) prevent performance.
Explanation #
May affect royalty payments or milestone dates.
Example #
A pandemic triggers a force‑majeure clause, delaying royalty reporting.
Practical application #
Provides protection against uncontrollable disruptions.
Challenges #
Determining when the clause applies and ensuring it does not become a loophole for non‑performance.
Frequent‑Use Royalty – A royalty structure that applies a higher rate for… #
Frequent‑Use Royalty – A royalty structure that applies a higher rate for products with high sales volume, reflecting greater commercial value.
Explanation #
Encourages the licensee to maximize sales while rewarding the licensor proportionally.
Example #
4 % royalty on sales up to $10 million, then 6 % on sales above that threshold.
Practical application #
Aligns incentives with market success.
Challenges #
Setting appropriate tiers and ensuring accurate sales tracking.
Future‑Use License – A license that grants rights to technology that is n… #
Future‑Use License – A license that grants rights to technology that is not yet fully developed or commercialized.
Explanation #
Allows parties to plan for later exploitation as the technology matures.
Example #
A university grants a future‑use license for a pre‑clinical compound that may become a drug.
Practical application #
Provides early access to emerging technologies.
Challenges #
Defining triggering events and handling uncertainty about final product form.
Government‑Sponsored Research Agreement (GSRA) – A contract where a gover… #
Government‑Sponsored Research Agreement (GSRA) – A contract where a government agency funds research in exchange for certain rights to the results.
Explanation #
Often includes clauses on licensing, march‑in rights, and reporting.
Example #
A defense department funds a university project and retains a non‑exclusive license to any resulting patents.
Practical application #
Enables public‑sector innovation.
Challenges #
Managing compliance with government procurement rules and ensuring proper royalty accounting.
Grant‑Back Clause – A provision whereby the licensee agrees to grant the… #
Grant‑Back Clause – A provision whereby the licensee agrees to grant the licensor a license to any improvements or new inventions arising from the licensed technology.
Explanation #
Protects the licensor’s ability to benefit from downstream innovations.
Example #
A biotech license includes a grant‑back of any new antibodies discovered using the licensed platform.
Practical application #
Encourages collaborative development.
Challenges #
Defining the scope of “improvements” and avoiding over‑reaching claims.
Grounds for Infringement – Legal bases on which a patent holder can claim… #
Grounds for Infringement – Legal bases on which a patent holder can claim that another party is unlawfully using the patented invention.
Explanation #
Include making, using, selling, or importing the patented subject matter without permission.
Example #
A competitor manufactures a device that incorporates a